欧洲 CAR-T 细胞治疗市场 – 行业趋势和 2028 年预测

Customize Your Report Customize Your Report 立即购买 立即购买 免费样本报告 免费样本报告
Home Pharmaceutical Europe Car T Cell Therapy Treatment Market
请求目录 请求目录 与分析师交谈 与分析师交谈 立即购买 立即购买 购买前请咨询 提前咨询 免费样本报告 免费样本报告

欧洲 CAR-T 细胞治疗市场 – 行业趋势和 2028 年预测

  • Pharmaceutical
  • Published Report
  • May 2021
  • Europe
  • 350 页面
  • 桌子數： 215
  • 图号： 51
立即购买 立即购买

>欧洲 CAR-T 细胞疗法治疗市场，按产品（自体 CAR-T 细胞、同种异体 CAR-T 细胞）、结构（第一代 CAR-T 细胞、第二代 CAR-T 细胞、第三代 CAR-T 细胞、第四代 CAR-T 细胞）、靶向抗原（实体肿瘤抗原、血液系统恶性肿瘤抗原、其他）、品牌（Yescarta、Kymriah、Tecartus、其他）、治疗应用（血液系统恶性肿瘤、胰腺癌、乳腺癌、肺癌、胃癌、多发性骨髓瘤、慢性淋巴细胞白血病、套细胞淋巴瘤、滤泡性淋巴瘤、弥漫性大 B 细胞淋巴瘤、急性淋巴细胞白血病、其他）、最终用户（医院、专科诊所、其他）、分销渠道（医院药房、其他）、国家（德国、英国、法国、意大利、西班牙、荷兰、俄罗斯、瑞士、土耳其、奥地利、挪威、匈牙利、立陶宛、爱尔兰、波兰、欧洲其他地区）行业趋势与预测（至 2028 年）

欧洲 CAR-T 细胞治疗市场

市场分析和见解：欧洲 CAR-T 细胞治疗市场

CAR-T 细胞疗法治疗市场预计将在 2021 年至 2028 年的预测期内实现市场增长。Data Bridge Market Research 分析，在 2021 年至 2028 年的预测期内，该市场以 29.4% 的复合年增长率增长，预计到 2028 年将达到 105.9465 亿美元。CAR-T 细胞疗法在癌症和传染病治疗中的使用增加成为 CAR-T 细胞疗法治疗市场增长的驱动力。

CAR-T 细胞疗法或嵌合抗原受体 T 细胞是经过基因改造的T 细胞，用于产生人工 T 细胞受体，可用作治疗各种癌症的免疫疗法。嵌合抗原受体是在实验室中设计的受体蛋白，可为 T 细胞提供针对特定蛋白质的新型能力。

人们对免疫疗法的认识不断提高，使人们接触到多种 CAR-T 疗法及其有效性，从而成为 CAR-T 细胞疗法市场发展的驱动力。疗法的不良副作用限制了一些人群选择这种疗法，从而影响了产品价值，因此限制了 CAR-T 细胞疗法市场的增长。管道产品的存在表明市场参与者不断从事创新药物的生产，因此为 CAR-T 细胞疗法市场提供了机会。免疫疗法的审批时间较长，限制了产品制造商在市场上获得潜在利益，并影响了整体市场规模，因此对 CAR-T 细胞疗法市场的增长构成了挑战。

CAR-T 细胞疗法治疗市场报告提供了市场份额、新发展和产品线分析、国内和本地市场参与者的影响的详细信息，分析了新兴收入领域、市场法规变化、产品批准、战略决策、产品发布、地域扩张和市场技术创新方面的机会。要了解分析和市场情况，请联系我们获取分析师简报，我们的团队将帮助您创建收入影响解决方案，以实现您的预​​期目标。

欧洲 CAR-T 细胞治疗市场

欧洲 CAR-T 细胞治疗市场范围和市场规模

CAR-T 细胞疗法治疗市场根据产品、结构、靶向抗原、品牌、治疗应用、最终用户和分销渠道进行细分。细分市场之间的增长有助于您分析利基增长领域和进入市场的策略，并确定您的核心应用领域和目标市场的差异。

  • 根据产品，CAR-T 细胞疗法治疗市场细分为自体 CAR-T 细胞和同种异体 CAR-T 细胞。2021 年，自体 CAR-T 细胞细分市场预计将主导 CAR-T 细胞疗法治疗市场，因为获批用于 CAR-T 细胞疗法的药物本质上是自体的。
  • 根据结构，CAR-T 细胞疗法治疗市场分为第一代 CAR-T 细胞、第二代 CAR-T 细胞、第三代 CAR-T 细胞和第四代 CAR-T 细胞。2021 年，第二代 CAR-T 细胞部分预计将主导 CAR-T 细胞疗法治疗市场，因为已获批准的疗法是基于第二代的结构。
  • 根据靶向抗原，CAR-T 细胞疗法治疗市场细分为实体肿瘤抗原、血液系统恶性肿瘤抗原和其他抗原。2021 年，血液系统恶性肿瘤抗原细分市场预计将主导 CAR-T 细胞疗法治疗市场，因为获批用于 CAR-T 细胞疗法的药物主要用于血液系统恶性肿瘤，并且正在进行广泛的研究开发。 
  • 根据品牌，CAR-T 细胞疗法治疗市场细分为 yescarta、kymriah、tecartus 等。2021 年，yescarta 细分市场预计将主导 CAR-T 细胞疗法治疗市场，因为 yescarta 是首个获批的肿瘤治疗类 CAR-T 细胞疗法。 
  • 根据治疗应用，CAR-T 细胞疗法治疗市场细分为血液系统恶性肿瘤、胰腺癌、乳腺癌、肺癌、胃癌、多发性骨髓瘤、慢性淋巴细胞白血病、套细胞淋巴瘤、滤泡性淋巴瘤、弥漫性大 B 细胞淋巴瘤、急性淋巴细胞白血病等。2021 年，血液系统恶性肿瘤领域预计将主导 CAR-T 细胞疗法治疗市场，因为 yescarta 占市场的主要收入，而滤泡性淋巴瘤是 yescarta 的主要适应症。
  • 根据最终用户，CAR-T 细胞疗法治疗市场分为医院、专科诊所和其他。2021 年，医院部门在 CAR-T 细胞疗法治疗市场中占据主导地位，因为 CAR-T 细胞疗法需要训练有素的专业人员和先进的技术实验室。 
  • 根据分销渠道，CAR-T 细胞治疗市场细分为医院药房和其他。2021 年，医院药房部门预计将主导 CAR-T 细胞治疗分销渠道，因为医院药房是医院的核心部分，所有输液相关和药物相关的配送均由药房部门销售。

CAR-T 细胞疗法治疗市场国家层面分析

对 CAR-T 细胞疗法治疗市场进行分析，并根据上述国家、产品、结构、靶向抗原、品牌、治疗应用、最终用户和分销渠道提供市场规模信息。

欧洲 CAR-T 细胞疗法治疗市场报告涵盖的国家包括德国、英国、法国、意大利、西班牙、荷兰、俄罗斯、瑞士、土耳其、奥地利、挪威、匈牙利、立陶宛、爱尔兰、波兰和欧洲其他地区。

由于癌症的普遍性，德国的自体 CAR-T 细胞领域在欧洲 CAR-T 细胞治疗市场占据主导地位。

报告的国家部分还提供了影响单个市场因素和国内市场法规变化，这些变化影响了市场的当前和未来趋势。新销售、替代销售、国家人口统计、监管法案和进出口关税等数据点是用于预测单个国家市场情景的一些主要指标。此外，在提供国家数据的预测分析时，还考虑了欧洲品牌的存在和可用性以及由于来自本地和国内品牌的激烈或稀少的竞争而面临的挑战、销售渠道的影响。

免疫疗法认知度的提高推动了 CAR-T 细胞疗法市场的增长 

CAR-T 细胞疗法治疗市场还为您提供有关 CAR-T 细胞疗法治疗行业每个国家增长情况的详细市场分析，包括 CAR-T 细胞疗法治疗销售、CAR-T 细胞疗法治疗技术进步的影响以及监管环境的变化及其对 CAR-T 细胞疗法治疗市场的支持。数据涵盖 2011 年至 2019 年的历史时期。

竞争格局和 CAR-T 细胞治疗市场份额分析

CAR-T 细胞疗法治疗市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、生产基地和设施、公司优势和劣势、产品发布、产品试验渠道、产品批准、专利、产品宽度和广度、应用优势、技术生命线曲线。以上提供的数据点仅与公司对 CAR-T 细胞疗法治疗市场的关注有关。

从事 CAR-T 细胞疗法治疗市场报告的主要公司包括 Autolus、Amgen Inc.、bluebird bio, Inc.、Adaptimmune Therapeutics plc.、Bristol-Myers Squibb Company、Johnson & Johnson Services, Inc.、AbbVie Inc.、Novartis AG、Kite Pharma（Gilead Sciences, Inc. 的子公司）、Cellectis、TC BIOPHARM、Celyad Oncology 以及其他国内和全球参与者。DBMR 分析师了解竞争优势并为每个竞争对手分别提供竞争分析。  

 全球范围内，多家公司推出了许多产品并签署了多项协议，这也加速了CAR-T细胞疗法市场的发展。

例如，

  • 2020 年 12 月，Atara Biotherapeutics, Inc. 与拜耳公司合作开发针对实体瘤的间皮素靶向 CAR-T 细胞疗法。根据协议，该公司高度专注于开发 ATA2271，以治疗恶性胸膜间皮瘤和非小细胞肺癌。此次合作加速了该公司对 ATA2271 的研发，并使其成为领先的同种异体 CAR-T 细胞疗法制造商。

市场参与者的合作、产品发布、业务扩展、奖励和认可、合资企业和其他策略正在增强公司在 CAR-T 细胞疗法治疗市场中的市场，这也为组织改善其在 CAR-T 细胞疗法治疗方面的产品提供了好处。 

SKU-

Get online access to the report on the World's First Market Intelligence Cloud

Sample Image Click on image to enlarge
  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

目录

  1. introduction
    1. OBJECTIVES OF THE STUDY
    2. MARKET DEFINITION
    3. OVERVIEW of EUROPE CAR-T cell therapy treatment MARKET
    4. LIMITATIONs
    5. MARKETS COVERED
  2. MARKET SEGMENTATION
    1. MARKETS COVERED
    2. geographical scope
    3. years considered for the study
    4. currency and pricing
    5. DBMR TRIPOD DATA VALIDATION MODEL
    6. MULTIVARIATE MODELLING
    7. PRODUCT LIFELINE CURVE
    8. primary interviews with key opinion leaders
    9. DBMR MARKET POSITION GRID
    10. vendor share analysis
    11. MARKET product COVERAGE GRID
    12. secondary sourcEs
    13. assumptions
  3. EXECUTIVE SUMMARY
  4. premium insight
  5. Epidemiology
  6. Pipeline analysis
  7. Market Overview
    1. Drivers
      1. increase in usage of CAR-T CELL THERAPY for the treatment of cancer and infectious diseases
      2. increasing prevalEnce of cancer
      3. rise in awareness about immunotherapies
      4. increasing investment in research and development
      5. adoption of CAR-T cell therapy treatment in Emerging markets
    2. restraints
      1. adverse side effects of therapies
      2. high cost associated with therapies
      3. logistic challenge associated with CAR-T therapies
      4. availability of alternatives for tumor treatment
    3. opportunities
      1. presence of pipeline producTs
      2. strategiC initiatives by market players
      3. Rise in expenditure in healthcare sector
    4. challenges
      1. long approval time for immunotherapies
      2. lack of skilled professionals
  8. IMPACT OF COVID-19 ON EUROPE CAR-T CELL THERAPY TREATMENT MARKET
    1. IMPACT ON PRICE
    2. IMPACT ON DEMAND
    3. IMPACT ON SUPPLY CHAIN
    4. STRATEGIC DECISION FOR MANUFACTURERS
    5. CONCLUSION
  9. Europe CAR-T Cell Therapy Treatment MARKET, BY PRODUCT
    1. overview
    2. Autologous CAR-T Cells
    3. Allogeneic CAR-T Cells
  10. Europe CAR-T CELL THERAPY TREATMENT MARKET, BY Structure
    1. overview
    2. First Generation CAR-T Cells
    3. Second Generation CAR-T Cells
    4. Third Generation CAR-T Cells
    5. Fourth Generation CAR-T Cells
  11. Europe CAR-T CELL THERAPY TREATMENTMARKET, BY Targeted Antigens
    1. overview
    2. Antigens on Hematologic Malignancies
      1. Cluster of Differentiation-19 (CD-19)
      2. Cluster of Differentiation-30 (CD-30)
      3. Cluster of Differentiation-22 (CD-22)
      4. Cluster of Differentiation-20 (CD-20)
      5. Cluster of Differentiation-33 (CD-33)
    3. Antigens on Solid Tumors
      1. Human Epidermal Growth Factor Receptor-2 (HER-2)
      2. Epidermal Growth Factor Receptors Variant III (EGFRV-III)
      3. Mesothelin (MSLN)
      4. Prostate-Specific Membrane Antigen (PSMA)
      5. Interleukin-13RA2 (IL13RA2)
      6. Disialoganglioside 2 (GD2)
      7. Glypican-3 (GPC3)
      8. Others
    4. OTHERS
  12. Europe CAR-T cell therapy treatment MARKET, BY brand
    1. overview
    2. yescarta
    3. KYMRIAH
    4. TECARTUS
    5. others
  13. Europe CAR-T cell therapy treatment MARKET, BY therapeutic application
    1. overview
    2. Follicular Lymphoma
    3. Diffuse Large B-Cell Lymphoma
    4. Acute Lymphoblastic Leukaemia (ALL)
    5. Mantle Cell Lymphoma
    6. Multiple Myeloma
    7. Hematologic Malignancies
      1. Leukemia
      2. Lymphoma
      3. Myeloma
      4. Others
    8. Lung Cancer
    9. Chronic Lymphocytic Leukemia
    10. Gastric Cancer
    11. Pancreatic Cancer
    12. Breast Cancer
    13. others
  14. Europe CAR-T cell therapy treatment MARKET, BY end user
    1. overview
    2. hospitals
    3. Specialty Clinics
    4. others
  15. Europe CAR-T cell therapy treatment MARKET, BY distribution channel
    1. overview
    2. hospital Pharmacy
    3. others
  16. Europe CAR-T cell therapy treatment market by geography
    1. EUROPE
      1. germany
      2. u.k
      3. France
      4. Italy
      5. Spain
      6. NETHERLANDS
      7. Russia
      8. Switzerland
      9. Belgium
      10. Turkey
      11. Austria
      12. Norway
      13. Hungary
      14. Lithuania
      15. Ireland
      16. Poland
      17. Rest of Europe
  17. Europe CAR-T Cell Therapy Treatment Market: COMPANY landscape
    1. company share analysis: europe
  18. swot analysis
  19. company profile
    1. kite pharma (A subsidiary of GILEAD SCIENCES, INC.)
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    2. Novartis AG
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    3. Abbvie inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    4. Adaptimmune Therapeutics plc
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    5. Amgen Inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PIPELINE PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    6. Atara Biotherapeutics, Inc.
      1. COMPANY SNAPSHOT
      2. PIPELINE PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    7. aurora biopharmA
      1. COMPANY SNAPSHOT
      2. PIPELINE PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    8. Autolus
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    9. Bellicum Phamaceuticals, Inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    10. BioAtla Inc.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    11. bluebird bio, inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    12. Bristol-Myers Squibb Company
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    13. carina biotech
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    14. cartherics pty ltd
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    15. cartesian therapeutics, inc.
      1. COMPANY SNAPSHOT
      2. PIPELINE PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    16. cellectis SA
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    17. celyad oncology SA
      1. COMPANY SNAPSHOT
      2. PIPELINE PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    18. Johnson & Johnson Services, Inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    19. sorrento therapeutics, INC.
      1. COMPANY SNAPSHOT
      2. PIPELINE PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    20. tc biopharm Limited
      1. COMPANY SNAPSHOT
      2. PIPELINE PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    21. tessa therapeutics ltd.
      1. COMPANY SNAPSHOT
      2. PIPELINE PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    22. tmunity therapeutics
      1. COMPANY SNAPSHOT
      2. PIPELINE PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    23. mustang bio
      1. COMPANY SNAPSHOT
      2. PIPELINE PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    24. Xyphos (A Subsidiary of Astellas Pharma Inc.)
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PIPELINE PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    25. ziopharm oncology, inc.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
  20. questionnaire
  21. related reports

表格列表

TABLE 1 Europe CAR-T cell therapy treatment Market, pipeline analysis

TABLE 2 Below provided are the alternative chemotherapies of CAR-T cell therapy:

TABLE 3 TOTAL HEALTH SPENDING BY THE U.S. (2015-2016)

TABLE 4 Europe CAR-T CELL THERAPY TREATMENTMarket, By MOLECULE, 2019-2028 (USD Million)

TABLE 5 Europe Autologous CAR-T Cells in CAR-T CELL THERAPY TREATMENTMarket, By Region, 2017-2028 (USD Million)

TABLE 6 Europe Allogeneic CAR-T Cells in CAR-T CELL THERAPY TREATMENTMARKET, By Region, 2019-2028 (USD Million)

TABLE 7 Europe CAR-T CELL THERAPY TREATMENTMarket, By Structure, 2019-2028 (USD Million)

Celyad is engaged in the manufacturing of CYAD-211, a first generation CAR-T cell therapy expressing BCMA targeting chimeric antigen receptor which interferes with the expression of the CD3ζ of T cell receptor complex.

TABLE 8 Europe First Generation CAR-T Cells in CAR-T CELL THERAPY TREATMENT Market, By Region, 2019-2028 (USD Million)

TABLE 9 Europe Second Generation CAR-T Cells in CAR-T CELL THERAPY TREATMENT Market, By Region, 2019-2028 (USD Million)

TABLE 10 Europe Third Generation CAR-T Cells in CAR-T CELL THERAPY TREATMENT Market, By Region, 2019-2028 (USD Million)

TABLE 11 Europe Third Generation CAR-T Cells in CAR-T CELL THERAPY TREATMENT Market, By Region, 2019-2028 (USD Million)

TABLE 12 Europe CAR-T CELL THERAPY TREATMENTMarket, By targeted antigens, 2019-2028 (USD Million)

TABLE 13 Europe Antigens on Hematologic Malignancies in CAR-T CELL THERAPY TREATMENT Market, By Region, 2019-2028 (USD Million)

TABLE 14 Europe Antigens on Hematologic Malignancies in CAR-T CELL THERAPY TREATMENT Market, By Antigens on Hematologic Malignancies, 2019-2028 (USD Million)

TABLE 15 Europe Antigens on Solid Tumors in CAR-T CELL THERAPY TREATMENTMarket , By Region, 2017-2028 (USD Million)

TABLE 16 Europe Antigens on Solid Tumors in CAR-T CELL THERAPY TREATMENT Market, By Antigens on Solid Tumors, 2019-2028 (USD Million)

TABLE 17 Europe others in CAR-T CELL THERAPY TREATMENTMarket , By Region, 2017-2028 (USD Million)

TABLE 18 Europe YESCARTA in CAR-T cell therapy treatment Market, By Region, 2017-2028 (USD Million)

TABLE 19 Europe YESCARTA in CAR-T cell therapy treatment Market, By Region, 2017-2028 (USD Million)

TABLE 20 Europe KYMRIAH in CAR-T cell therapy treatment Market, By Region, 2017-2028 (USD Million)

TABLE 21 Europe TECARTUS in CAR-T cell therapy treatment Market, By Region, 2017-2028 (USD Million)

TABLE 22 Europe others in CAR-T cell therapy treatment Market, By Region, 2017-2028 (USD Million)

TABLE 23 Europe CAR-T cell therapy treatment Market, By therapeutic type, 2019-2028 (USD Million)

TABLE 24 Europe Follicular Lymphoma in CAR-T cell therapy treatment Market, By therapeutic type, 2017-2028 (USD Million)

TABLE 25 Europe Diffuse Large B-Cell Lymphoma in CAR-T cell therapy treatment Market, By Region, 2017-2028 (USD Million)

TABLE 26 Europe ACUTE LYMPHOBLASTIC LEUKAEMIA (ALL) in CAR-T cell therapy treatment Market, By Region, 2017-2028 (USD Million)

TABLE 27 Europe Mantle Cell Lymphoma in CAR-T cell therapy treatment Market, By Region, 2017-2028 (USD Million)

TABLE 28 Europe Multiple Myeloma in CAR-T cell therapy treatment Market, By Region, 2017-2028 (USD Million)

TABLE 29 Europe hematologic malignancies in CAR-T cell therapy treatment Market, By Region, 2017-2028 (USD Million)

TABLE 30 Europe hematologic malignancies on Solid Tumors in CAR-T CELL THERAPY TREATMENT Market, By therapeutic application, 2019-2028 (USD Million)

TABLE 31 Europe Lung Cancer in CAR-T cell therapy treatment Market, By Region, 2017-2028 (USD Million)

TABLE 32 Europe chronic lymphocytic leukemia in CAR-T cell therapy treatment Market, By Region, 2017-2028 (USD Million)

TABLE 33 Europe gastric cancer in CAR-T cell therapy treatment Market, By Region, 2017-2028 (USD Million)

TABLE 34 Europe pancreatic cancer in CAR-T cell therapy treatment Market, By Region, 2017-2028 (USD Million)

TABLE 35 Europe breast cancer in CAR-T cell therapy treatment Market, By Region, 2017-2028 (USD Million)

TABLE 36 Europe others in CAR-T cell therapy treatment Market, By Region, 2017-2028 (USD Million)

TABLE 37 Europe CAR-T cell therapy treatment Market, By END USER, 2019-2028 (USD Million)

TABLE 38 Europe hospitals in CAR-T cell therapy treatment Market, By therapeutic type, 2017-2028 (USD Million)

TABLE 39 Europe specialty clinics in CAR-T cell therapy treatment Market, By Region, 2017-2028 (USD Million)

TABLE 40 Europe others in CAR-T cell therapy treatment Market, By Region, 2017-2028 (USD Million)

TABLE 41 Europe CAR-T cell therapy treatment Market, By distribution channel, 2019-2028 (USD Million)

TABLE 42 Europe hospital pharmacy in CAR-T cell therapy treatment Market, By distribution channel, 2017-2028 (USD Million)

TABLE 43 Europe others in CAR-T cell therapy treatment Market, By Region, 2017-2028 (USD Million)

TABLE 44 Europe CAR-T Cell Therapy Treatment Market, By Region, 2019-2028 (USD Million)

TABLE 45 Europe CAR-T Cell Therapy Treatment Market, By Product, 2019-2028 (USD Million)

TABLE 46 Europe CAR-T Cell Therapy Treatment Market, By Structure 2019-2028 (USD Million)

TABLE 47 Europe CAR-T Cell Therapy Treatment Market, By Targeted Antigens, 2019-2028 (USD Million)

TABLE 48 europe Antigens on Hematologic Malignancies in CAR-T Cell Therapy Treatment Market, By Targeted Antigens, 2019-2028 (USD Million)

TABLE 49 Europe Antigens on Solid Tumors in CAR-T Cell Therapy Treatment Market, By Targeted Antigens, 2019-2028 (USD Million)

TABLE 50 Europe CAR-T Cell Therapy Treatment Market, By Brand, 2019-2028 (USD Million)

TABLE 51 Europe CAR-T Cell Therapy Treatment Market, By Therapeutic Application, 2019-2028 (USD Million)

TABLE 52 Europe Hematologic malignancies in CAR-T Cell Therapy Treatment Market, By Therapeutic Application, 2019-2028 (USD Million)

TABLE 53 Europe CAR-T Cell Therapy Treatment Market, By End User, 2019-2028 (USD Million)

TABLE 54 Europe CAR-T Cell Therapy Treatment Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 55 Germany CAR-T Cell Therapy Treatment Market, By Product, 2019-2028 (USD Million)

TABLE 56 Germany CAR-T Cell Therapy Treatment Market, By Structure 2019-2028 (USD Million)

TABLE 57 Germany CAR-T Cell Therapy Treatment Market, By Targeted Antigens, 2019-2028 (USD Million)

TABLE 58 Germany Antigens on Hematologic Malignancies in CAR-T Cell Therapy Treatment Market, By Targeted Antigens, 2019-2028 (USD Million)

TABLE 59 Germany Antigens on Solid Tumors in CAR-T Cell Therapy Treatment Market, By Targeted Antigens, 2019-2028 (USD Million)

TABLE 60 Germany CAR-T Cell Therapy Treatment Market, By Brand, 2019-2028 (USD Million)

TABLE 61 Germany CAR-T Cell Therapy Treatment Market, By Therapeutic Application, 2019-2028 (USD Million)

TABLE 62 Germany Hematologic malignancies in CAR-T Cell Therapy Treatment Market, By Therapeutic Application, 2019-2028 (USD Million)

TABLE 63 Germany CAR-T Cell Therapy Treatment Market, By End User, 2019-2028 (USD Million)

TABLE 64 Germany CAR-T Cell Therapy Treatment Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 65 U.K CAR-T Cell Therapy Treatment Market, By Product, 2019-2028 (USD Million)

TABLE 66 U.K CAR-T Cell Therapy Treatment Market, By Structure 2019-2028 (USD Million)

TABLE 67 U.K CAR-T Cell Therapy Treatment Market, By Targeted Antigens, 2019-2028 (USD Million)

TABLE 68 U.K Antigens on Hematologic Malignancies in CAR-T Cell Therapy Treatment Market, By Targeted Antigens, 2019-2028 (USD Million)

TABLE 69 U.K Antigens on Solid Tumors in CAR-T Cell Therapy Treatment Market, By Targeted Antigens, 2019-2028 (USD Million)

TABLE 70 U.K CAR-T Cell Therapy Treatment Market, By Brand, 2019-2028 (USD Million)

TABLE 71 U.K CAR-T Cell Therapy Treatment Market, By Therapeutic Application, 2019-2028 (USD Million)

TABLE 72 U.K Hematologic malignancies in CAR-T Cell Therapy Treatment Market, By Therapeutic Application, 2019-2028 (USD Million)

TABLE 73 U.K CAR-T Cell Therapy Treatment Market, By End User, 2019-2028 (USD Million)

TABLE 74 U.K CAR-T Cell Therapy Treatment Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 75 FRANCE CAR-T Cell Therapy Treatment Market, By Product, 2019-2028 (USD Million)

TABLE 76 FRANCE CAR-T Cell Therapy Treatment Market, By Structure 2019-2028 (USD Million)

TABLE 77 FRANCE CAR-T Cell Therapy Treatment Market, By Targeted Antigens, 2019-2028 (USD Million)

TABLE 78 FRANCE Antigens on Hematologic Malignancies in CAR-T Cell Therapy Treatment Market, By Targeted Antigens, 2019-2028 (USD Million)

TABLE 79 FRANCE Antigens on Solid Tumors in CAR-T Cell Therapy Treatment Market, By Targeted Antigens, 2019-2028 (USD Million)

TABLE 80 FRANCE CAR-T Cell Therapy Treatment Market, By Brand, 2019-2028 (USD Million)

TABLE 81 FRANCE CAR-T Cell Therapy Treatment Market, By Therapeutic Application, 2019-2028 (USD Million)

TABLE 82 FRANCE Hematologic malignancies in CAR-T Cell Therapy Treatment Market, By Therapeutic Application, 2019-2028 (USD Million)

TABLE 83 FRANCE CAR-T Cell Therapy Treatment Market, By End User, 2019-2028 (USD Million)

TABLE 84 FRANCE CAR-T Cell Therapy Treatment Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 85 ITALY CAR-T Cell Therapy Treatment Market, By Product, 2019-2028 (USD Million)

TABLE 86 ITALY CAR-T Cell Therapy Treatment Market, By Structure 2019-2028 (USD Million)

TABLE 87 ITALY CAR-T Cell Therapy Treatment Market, By Targeted Antigens, 2019-2028 (USD Million)

TABLE 88 ITALY Antigens on Hematologic Malignancies in CAR-T Cell Therapy Treatment Market, By Targeted Antigens, 2019-2028 (USD Million)

TABLE 89 ITALY Antigens on Solid Tumors in CAR-T Cell Therapy Treatment Market, By Targeted Antigens, 2019-2028 (USD Million)

TABLE 90 ITALY CAR-T Cell Therapy Treatment Market, By Brand, 2019-2028 (USD Million)

TABLE 91 ITALY CAR-T Cell Therapy Treatment Market, By Therapeutic Application, 2019-2028 (USD Million)

TABLE 92 ITALY Hematologic malignancies in CAR-T Cell Therapy Treatment Market, By Therapeutic Application, 2019-2028 (USD Million)

TABLE 93 ITALY CAR-T Cell Therapy Treatment Market, By End User, 2019-2028 (USD Million)

TABLE 94 ITALY CAR-T Cell Therapy Treatment Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 95 Spain CAR-T Cell Therapy Treatment Market, By Product, 2019-2028 (USD Million)

TABLE 96 SPAIN CAR-T Cell Therapy Treatment Market, By Structure 2019-2028 (USD Million)

TABLE 97 SPAIN CAR-T Cell Therapy Treatment Market, By Targeted Antigens, 2019-2028 (USD Million)

TABLE 98 SPAIN Antigens on Hematologic Malignancies in CAR-T Cell Therapy Treatment Market, By Targeted Antigens, 2019-2028 (USD Million)

TABLE 99 SPAIN Antigens on Solid Tumors in CAR-T Cell Therapy Treatment Market, By Targeted Antigens, 2019-2028 (USD Million)

TABLE 100 SPAIN CAR-T Cell Therapy Treatment Market, By Brand, 2019-2028 (USD Million)

TABLE 101 SPAIN CAR-T Cell Therapy Treatment Market, By Therapeutic Application, 2019-2028 (USD Million)

TABLE 102 SPAIN Hematologic malignancies in CAR-T Cell Therapy Treatment Market, By Therapeutic Application, 2019-2028 (USD Million)

TABLE 103 SPAIN CAR-T Cell Therapy Treatment Market, By End User, 2019-2028 (USD Million)

TABLE 104 SPAIN CAR-T Cell Therapy Treatment Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 105 netherlands CAR-T Cell Therapy Treatment Market, By Product, 2019-2028 (USD Million)

TABLE 106 NETHERLANDS CAR-T Cell Therapy Treatment Market, By Structure 2019-2028 (USD Million)

TABLE 107 NETHERLANDS CAR-T Cell Therapy Treatment Market, By Targeted Antigens, 2019-2028 (USD Million)

TABLE 108 NETHERLANDS Antigens on Hematologic Malignancies in CAR-T Cell Therapy Treatment Market, By Targeted Antigens, 2019-2028 (USD Million)

TABLE 109 NETHERLANDS Antigens on Solid Tumors in CAR-T Cell Therapy Treatment Market, By Targeted Antigens, 2019-2028 (USD Million)

TABLE 110 NETHERLANDS CAR-T Cell Therapy Treatment Market, By Brand, 2019-2028 (USD Million)

TABLE 111 NETHERLANDS CAR-T Cell Therapy Treatment Market, By Therapeutic Application, 2019-2028 (USD Million)

TABLE 112 NETHERLANDS Hematologic malignancies in CAR-T Cell Therapy Treatment Market, By Therapeutic Application, 2019-2028 (USD Million)

TABLE 113 NETHERLANDS CAR-T Cell Therapy Treatment Market, By End User, 2019-2028 (USD Million)

TABLE 114 NETHERLANDS CAR-T Cell Therapy Treatment Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 115 Russia CAR-T Cell Therapy Treatment Market, By Product, 2019-2028 (USD Million)

TABLE 116 RUSSIA CAR-T Cell Therapy Treatment Market, By Structure 2019-2028 (USD Million)

TABLE 117 RUSSIA CAR-T Cell Therapy Treatment Market, By Targeted Antigens, 2019-2028 (USD Million)

TABLE 118 RUSSIA Antigens on Hematologic Malignancies in CAR-T Cell Therapy Treatment Market, By Targeted Antigens, 2019-2028 (USD Million)

TABLE 119 RUSSIA Antigens on Solid Tumors in CAR-T Cell Therapy Treatment Market, By Targeted Antigens, 2019-2028 (USD Million)

TABLE 120 RUSSIA CAR-T Cell Therapy Treatment Market, By Brand, 2019-2028 (USD Million)

TABLE 121 RUSSIA CAR-T Cell Therapy Treatment Market, By Therapeutic Application, 2019-2028 (USD Million)

TABLE 122 RUSSIA Hematologic malignancies in CAR-T Cell Therapy Treatment Market, By Therapeutic Application, 2019-2028 (USD Million)

TABLE 123 RUSSIA CAR-T Cell Therapy Treatment Market, By End User, 2019-2028 (USD Million)

TABLE 124 RUSSIA CAR-T Cell Therapy Treatment Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 125 Switzerland CAR-T Cell Therapy Treatment Market, By Product, 2019-2028 (USD Million)

TABLE 126 SWITZERLAND CAR-T Cell Therapy Treatment Market, By Structure 2019-2028 (USD Million)

TABLE 127 SWITZERLAND CAR-T Cell Therapy Treatment Market, By Targeted Antigens, 2019-2028 (USD Million)

TABLE 128 SWITZERLAND Antigens on Hematologic Malignancies in CAR-T Cell Therapy Treatment Market, By Targeted Antigens, 2019-2028 (USD Million)

TABLE 129 SWITZERLAND Antigens on Solid Tumors in CAR-T Cell Therapy Treatment Market, By Targeted Antigens, 2019-2028 (USD Million)

TABLE 130 SWITZERLAND CAR-T Cell Therapy Treatment Market, By Brand, 2019-2028 (USD Million)

TABLE 131 SWITZERLAND CAR-T Cell Therapy Treatment Market, By Therapeutic Application, 2019-2028 (USD Million)

TABLE 132 SWITZERLAND Hematologic malignancies in CAR-T Cell Therapy Treatment Market, By Therapeutic Application, 2019-2028 (USD Million)

TABLE 133 SWITZERLAND CAR-T Cell Therapy Treatment Market, By End User, 2019-2028 (USD Million)

TABLE 134 SWITZERLAND CAR-T Cell Therapy Treatment Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 135 belgium CAR-T Cell Therapy Treatment Market, By Product, 2019-2028 (USD Million)

TABLE 136 BELGIUM CAR-T Cell Therapy Treatment Market, By Structure 2019-2028 (USD Million)

TABLE 137 BELGIUM CAR-T Cell Therapy Treatment Market, By Targeted Antigens, 2019-2028 (USD Million)

TABLE 138 BELGIUM Antigens on Hematologic Malignancies in CAR-T Cell Therapy Treatment Market, By Targeted Antigens, 2019-2028 (USD Million)

TABLE 139 BELGIUM Antigens on Solid Tumors in CAR-T Cell Therapy Treatment Market, By Targeted Antigens, 2019-2028 (USD Million)

TABLE 140 BELGIUM CAR-T Cell Therapy Treatment Market, By Brand, 2019-2028 (USD Million)

TABLE 141 BELGIUM CAR-T Cell Therapy Treatment Market, By Therapeutic Application, 2019-2028 (USD Million)

TABLE 142 BELGIUM Hematologic malignancies in CAR-T Cell Therapy Treatment Market, By Therapeutic Application, 2019-2028 (USD Million)

TABLE 143 BELGIUM CAR-T Cell Therapy Treatment Market, By End User, 2019-2028 (USD Million)

TABLE 144 BELGIUM CAR-T Cell Therapy Treatment Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 145 turkey CAR-T Cell Therapy Treatment Market, By Product, 2019-2028 (USD Million)

TABLE 146 TURKEY CAR-T Cell Therapy Treatment Market, By Structure 2019-2028 (USD Million)

TABLE 147 TURKEY CAR-T Cell Therapy Treatment Market, By Targeted Antigens, 2019-2028 (USD Million)

TABLE 148 TURKEY Antigens on Hematologic Malignancies in CAR-T Cell Therapy Treatment Market, By Targeted Antigens, 2019-2028 (USD Million)

TABLE 149 TURKEY Antigens on Solid Tumors in CAR-T Cell Therapy Treatment Market, By Targeted Antigens, 2019-2028 (USD Million)

TABLE 150 TURKEY CAR-T Cell Therapy Treatment Market, By Brand, 2019-2028 (USD Million)

TABLE 151 TURKEY CAR-T Cell Therapy Treatment Market, By Therapeutic Application, 2019-2028 (USD Million)

TABLE 152 TURKEY Hematologic malignancies in CAR-T Cell Therapy Treatment Market, By Therapeutic Application, 2019-2028 (USD Million)

TABLE 153 TURKEY CAR-T Cell Therapy Treatment Market, By End User, 2019-2028 (USD Million)

TABLE 154 turkey CAR-T Cell Therapy Treatment Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 155 Austria CAR-T Cell Therapy Treatment Market, By Product, 2019-2028 (USD Million)

TABLE 156 AUSTRIA CAR-T Cell Therapy Treatment Market, By Structure 2019-2028 (USD Million)

TABLE 157 AUSTRIA CAR-T Cell Therapy Treatment Market, By Targeted Antigens, 2019-2028 (USD Million)

TABLE 158 AUSTRIA Antigens on Hematologic Malignancies in CAR-T Cell Therapy Treatment Market, By Targeted Antigens, 2019-2028 (USD Million)

TABLE 159 AUSTRIA Antigens on Solid Tumors in CAR-T Cell Therapy Treatment Market, By Targeted Antigens, 2019-2028 (USD Million)

TABLE 160 AUSTRIA CAR-T Cell Therapy Treatment Market, By Brand, 2019-2028 (USD Million)

TABLE 161 AUSTRIA CAR-T Cell Therapy Treatment Market, By Therapeutic Application, 2019-2028 (USD Million)

TABLE 162 AUSTRIA Hematologic malignancies in CAR-T Cell Therapy Treatment Market, By Therapeutic Application, 2019-2028 (USD Million)

TABLE 163 AUSTRIA CAR-T Cell Therapy Treatment Market, By End User, 2019-2028 (USD Million)

TABLE 164 Austria CAR-T Cell Therapy Treatment Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 165 norway CAR-T Cell Therapy Treatment Market, By Product, 2019-2028 (USD Million)

TABLE 166 NORWAY CAR-T Cell Therapy Treatment Market, By Structure 2019-2028 (USD Million)

TABLE 167 NORWAY CAR-T Cell Therapy Treatment Market, By Targeted Antigens, 2019-2028 (USD Million)

TABLE 168 NORWAY Antigens on Hematologic Malignancies in CAR-T Cell Therapy Treatment Market, By Targeted Antigens, 2019-2028 (USD Million)

TABLE 169 NORWAY Antigens on Solid Tumors in CAR-T Cell Therapy Treatment Market, By Targeted Antigens, 2019-2028 (USD Million)

TABLE 170 NORWAY CAR-T Cell Therapy Treatment Market, By Brand, 2019-2028 (USD Million)

TABLE 171 NORWAY CAR-T Cell Therapy Treatment Market, By Therapeutic Application, 2019-2028 (USD Million)

TABLE 172 NORWAY Hematologic malignancies in CAR-T Cell Therapy Treatment Market, By Therapeutic Application, 2019-2028 (USD Million)

TABLE 173 NORWAY CAR-T Cell Therapy Treatment Market, By End User, 2019-2028 (USD Million)

TABLE 174 Norway CAR-T Cell Therapy Treatment Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 175 Hungary CAR-T Cell Therapy Treatment Market, By Product, 2019-2028 (USD Million)

TABLE 176 HUNGARY CAR-T Cell Therapy Treatment Market, By Structure 2019-2028 (USD Million)

TABLE 177 HUNGARY CAR-T Cell Therapy Treatment Market, By Targeted Antigens, 2019-2028 (USD Million)

TABLE 178 HUNGARY Antigens on Hematologic Malignancies in CAR-T Cell Therapy Treatment Market, By Targeted Antigens, 2019-2028 (USD Million)

TABLE 179 HUNGARY Antigens on Solid Tumors in CAR-T Cell Therapy Treatment Market, By Targeted Antigens, 2019-2028 (USD Million)

TABLE 180 HUNGARY CAR-T Cell Therapy Treatment Market, By Brand, 2019-2028 (USD Million)

TABLE 181 HUNGARY CAR-T Cell Therapy Treatment Market, By Therapeutic Application, 2019-2028 (USD Million)

TABLE 182 HUNGARY Hematologic malignancies in CAR-T Cell Therapy Treatment Market, By Therapeutic Application, 2019-2028 (USD Million)

TABLE 183 HUNGARY CAR-T Cell Therapy Treatment Market, By End User, 2019-2028 (USD Million)

TABLE 184 Hungary CAR-T Cell Therapy Treatment Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 185 Lithuania CAR-T Cell Therapy Treatment Market, By Product, 2019-2028 (USD Million)

TABLE 186 LITHUANIA CAR-T Cell Therapy Treatment Market, By Structure 2019-2028 (USD Million)

TABLE 187 LITHUANIA CAR-T Cell Therapy Treatment Market, By Targeted Antigens, 2019-2028 (USD Million)

TABLE 188 LITHUANIA Antigens on Hematologic Malignancies in CAR-T Cell Therapy Treatment Market, By Targeted Antigens, 2019-2028 (USD Million)

TABLE 189 LITHUANIA Antigens on Solid Tumors in CAR-T Cell Therapy Treatment Market, By Targeted Antigens, 2019-2028 (USD Million)

TABLE 190 LITHUANIA CAR-T Cell Therapy Treatment Market, By Brand, 2019-2028 (USD Million)

TABLE 191 LITHUANIA CAR-T Cell Therapy Treatment Market, By Therapeutic Application, 2019-2028 (USD Million)

TABLE 192 LITHUANIA Hematologic malignancies in CAR-T Cell Therapy Treatment Market, By Therapeutic Application, 2019-2028 (USD Million)

TABLE 193 LITHUANIA CAR-T Cell Therapy Treatment Market, By End User, 2019-2028 (USD Million)

TABLE 194 Lithuania CAR-T Cell Therapy Treatment Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 195 Ireland CAR-T Cell Therapy Treatment Market, By Product, 2019-2028 (USD Million)

TABLE 196 IRELAND CAR-T Cell Therapy Treatment Market, By Structure 2019-2028 (USD Million)

TABLE 197 IRELAND CAR-T Cell Therapy Treatment Market, By Targeted Antigens, 2019-2028 (USD Million)

TABLE 198 IRELAND Antigens on Hematologic Malignancies in CAR-T Cell Therapy Treatment Market, By Targeted Antigens, 2019-2028 (USD Million)

TABLE 199 IRELAND Antigens on Solid Tumors in CAR-T Cell Therapy Treatment Market, By Targeted Antigens, 2019-2028 (USD Million)

TABLE 200 IRELAND CAR-T Cell Therapy Treatment Market, By Brand, 2019-2028 (USD Million)

TABLE 201 IRELAND CAR-T Cell Therapy Treatment Market, By Therapeutic Application, 2019-2028 (USD Million)

TABLE 202 IRELAND Hematologic malignancies in CAR-T Cell Therapy Treatment Market, By Therapeutic Application, 2019-2028 (USD Million)

TABLE 203 IRELAND CAR-T Cell Therapy Treatment Market, By End User, 2019-2028 (USD Million)

TABLE 204 ireland CAR-T Cell Therapy Treatment Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 205 Poland CAR-T Cell Therapy Treatment Market, By Product, 2019-2028 (USD Million)

TABLE 206 POLAND CAR-T Cell Therapy Treatment Market, By Structure 2019-2028 (USD Million)

TABLE 207 POLAND CAR-T Cell Therapy Treatment Market, By Targeted Antigens, 2019-2028 (USD Million)

TABLE 208 POLAND Antigens on Hematologic Malignancies in CAR-T Cell Therapy Treatment Market, By Targeted Antigens, 2019-2028 (USD Million)

TABLE 209 POLAND Antigens on Solid Tumors in CAR-T Cell Therapy Treatment Market, By Targeted Antigens, 2019-2028 (USD Million)

TABLE 210 POLAND CAR-T Cell Therapy Treatment Market, By Brand, 2019-2028 (USD Million)

TABLE 211 POLAND CAR-T Cell Therapy Treatment Market, By Therapeutic Application, 2019-2028 (USD Million)

TABLE 212 POLAND Hematologic malignancies in CAR-T Cell Therapy Treatment Market, By Therapeutic Application, 2019-2028 (USD Million)

TABLE 213 POLAND CAR-T Cell Therapy Treatment Market, By End User, 2019-2028 (USD Million)

TABLE 214 Poland CAR-T Cell Therapy Treatment Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 215 Rest of Europe CAR-T Cell Therapy Treatment Market, By Product, 2019-2028 (USD Million)

图片列表

FIGURE 1 Europe CAR-T cell therapy treatment MARKET: SEGMENTATION

FIGURE 2 EUROPE CAR-T cell therapy treatment MARKET: DATA TRIANGULATION

FIGURE 3 Europe CAR-T cell therapy treatment Market: DROC ANALYSIS

FIGURE 4 Europe CAR-T cell therapy treatment market: Europe VS REGIONAL MARKET ANALYSIS

FIGURE 5 Europe CAR-T cell therapy treatment Market: COMPANY RESEARCH ANALYSIS

FIGURE 6 EUROPE CAR-T cell therapy treatment MARKET: MULTIVARIATE MODELLING

FIGURE 7 EUROPE CAR-T cell therapy treatment MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 8 EUROPE CAR-T cell therapy treatment MARKET: DBMR MARKET POSITION GRID

FIGURE 9 EUROPE CAR-T cell therapy treatment MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 EUROPE car-t cell therapy treatment MARKET: MARKET product COVERAGE GRID

FIGURE 11 Europe car-t cell therapy treatment market: SEGMENTATION

FIGURE 12 increasing investment in research and development is expected to drive THE Europe CAR-T cell therapy treatment market IN THE FORECAST PERIOD OF 2021 to 2028

FIGURE 13 Autologus car-t cells SEGMENT is expected to account for the largest share of the Europe CAR-T CELL THERAPY TREATMENT market in 2021 & 2028

FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGEs OF Europe CAR-T cell therapy treatment Market

FIGURE 15 New Cancer Cases Worldwide, (2018)

FIGURE 16 Europe Cancer Incidence (2018)

FIGURE 17 Cancer Death By Type (in million), world, 2017

FIGURE 18 Europe CAR-T CELL THERAPY TREATMENTmarket: BY Product, 2021

FIGURE 19 Europe CAR-T CELL THERAPY TREATMENTmarket: BY Product, 2019-2028 (USD Million)

FIGURE 20 Europe CAR-T CELL THERAPY TREATMENTmarket: BY Product, CAGR (2021-2028)

FIGURE 21 Europe CAR-T CELL THERAPY TREATMENTmarket: BY Product, LIFELINE CURVE

FIGURE 22 Europe CAR-T CELL THERAPY TREATMENTmarket: BY structure, 2021

FIGURE 23 Europe CAR-T CELL THERAPY TREATMENTmarket: BY structure, 2019-2028 (USD Million)

FIGURE 24 Europe CAR-T CELL THERAPY TREATMENTmarket: BY structure, CAGR (2021-2028)

FIGURE 25 Europe CAR-T CELL THERAPY TREATMENTmarket: BY structure, LIFELINE CURVE

FIGURE 26 Europe CAR-T CELL THERAPY TREATMENTmarket: BY targeted antigens, 2021

FIGURE 27 Europe CAR-T CELL THERAPY TREATMENTmarket: BY targeted antigens, 2019-2028 (USD Million)

FIGURE 28 Europe CAR-T CELL THERAPY TREATMENTmarket: BY targeted antigens, CAGR (2021-2028)

FIGURE 29 Europe CAR-T CELL THERAPY TREATMENTmarket: BY targeted antigens, LIFELINE CURVE

FIGURE 30 Europe CAR-T cell therapy treatment market: BY brand, 2020

FIGURE 31 Europe CAR-T cell therapy treatment market: BY brand, 2020-2028 (USD Million)

FIGURE 32 Europe CAR-T cell therapy treatment market: BY brand, CAGR (2020-2028)

FIGURE 33 Europe CAR-T cell therapy treatment market: BY brand, LIFELINE CURVE

FIGURE 34 Europe CAR-T cell therapy treatment market: BY therapeutic application, 2020

FIGURE 35 Europe CAR-T cell therapy treatment market: BY therapeutic application, 2020-2028 (USD Million)

FIGURE 36 Europe CAR-T cell therapy treatment market: BY therapeutic application, CAGR (2020-2028)

FIGURE 37 Europe CAR-T cell therapy treatment market: BY therapeutic application, LIFELINE CURVE

FIGURE 38 Europe CAR-T cell therapy treatment market: BY END USER, 2020

FIGURE 39 Europe CAR-T cell therapy treatment market: BY END USER, 2020-2028 (USD Million)

FIGURE 40 Europe CAR-T cell therapy treatment market: BY END USER, CAGR (2020-2028)

FIGURE 41 Europe CAR-T cell therapy treatment market: BY END USER, LIFELINE CURVE

FIGURE 42 Europe CAR-T cell therapy treatment market: BY distribution channel, 2020

FIGURE 43 Europe CAR-T cell therapy treatment market: BY distribution channel, 2020-2028 (USD Million)

FIGURE 44 Europe CAR-T cell therapy treatment market: BY distribution channel, CAGR (2020-2028)

FIGURE 45 Europe CAR-T cell therapy treatment market: BY distribution channel, LIFELINE CURVE

FIGURE 46 Europe CAR-T CELL THERAPY TREATMENT market: SNAPSHOT (2020)

FIGURE 47 Europe CAR-T CELL THERAPY TREATMENT market: BY COUNTRY (2020)

FIGURE 48 Europe CAR-T CELL THERAPY TREATMENT market: BY COUNTRY (2021 & 2028)

FIGURE 49 Europe CAR-T CELL THERAPY TREATMENT market: BY COUNTRY (2020 & 2028)

FIGURE 50 Europe CAR-T CELL THERAPY TREATMENT market: BY product (2021-2028)

FIGURE 51 EUROPE CAR-T Cell Therapy Treatment Market: company share 2020 (%)

查看详细信息 Right Arrow

研究方法

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

可定制

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

浏览相关页面

Banner